Home / Recalls / Homeocare Laboratories, Inc. / D-0886-2023

D-0886-2023 Class II Terminated

Recalled by Homeocare Laboratories, Inc. — Yonkers, NY

Recall Details

Product Type
Drugs
Report Date
July 5, 2023
Initiation Date
June 5, 2023
Termination Date
September 16, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
130,762/16 oz. tottles

Product Description

StellaLife VEGA Oral Care Rinse, 16 fl oz (473 ml) bottles, Peppermint, Distributed by: StellaLife, Inc., Aventura, FL NDC 69685-103-16

Reason for Recall

cGMP deviations

Distribution Pattern

Product was distributed USA nationwide.

Code Information

Lot # 2357B,2333, exp. date Sep-2; 2367C, 2367D, exp. date Nov-23; 2367E, 2367F, exp. date Jan-24; 2395A, 2406, exp. date Feb-2; 2395B, exp. date Mar-24; 2395C, exp. date Apr-24

Other recalls by Homeocare Laboratories, Inc.

  • D-0609-2024 Class I — STELLALIFE VEGA Oral Care, Spray, Unflavored, 1 fl oz (30 ml) bottles, Distribut (June 5, 2024)
  • D-0610-2024 Class II — STELLALIFE ADVANCED FORMULA Peppermint, VEGA Oral Care, Rinse, 16 fl oz (473 ml (June 5, 2024)
  • D-0882-2023 Class II — Bebelyn Colic Drops Homeopathic Remedy, 0.5 FL Oz (15 mL) bottles, distributed b (June 5, 2023)
  • D-0888-2023 Class II — StellaLife VEGA Oral Care Spray, 1 fl oz (30 ml) bottles, Distributed by: Stella (June 5, 2023)
  • D-0884-2023 Class II — DoloEar Earache Drops, 0.50 fl. oz. bottles, Distributed by Pharmadel LLC, Georg (June 5, 2023)
  • D-0880-2023 Class II — Kanjo Homeopathic Pain Relief Cream With Arnica, NET WT 2 oz (56.70G), Manufactu (June 5, 2023)
  • D-0883-2023 Class II — Babelyn Diarrhea Drops Homeopathic Remedy, 0.5 fl. oz. (15 mL) bottles, Distribu (June 5, 2023)
  • D-0881-2023 Class II — Arnica 7 Cream, net wt 2 oz (56.7g), Manufactured for: Brazmedics, LLC, New York (June 5, 2023)
  • D-0887-2023 Class II — StellaLife VEGA Oral Care Rinse, 16 fl oz (473 ml) bottles, Coconut, Distributed (June 5, 2023)
  • D-0885-2023 Class II — SnoreStop Naso Spray Bulk, liquid, Distributed by Green Pharma, NDC 61152-199-99 (June 5, 2023)